CN107648676A - 一种可降解铁基心血管支架材料及其制备方法 - Google Patents

一种可降解铁基心血管支架材料及其制备方法 Download PDF

Info

Publication number
CN107648676A
CN107648676A CN201711089471.4A CN201711089471A CN107648676A CN 107648676 A CN107648676 A CN 107648676A CN 201711089471 A CN201711089471 A CN 201711089471A CN 107648676 A CN107648676 A CN 107648676A
Authority
CN
China
Prior art keywords
powder
iron
degradable
angiocarpy bracket
bracket material
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Pending
Application number
CN201711089471.4A
Other languages
English (en)
Inventor
谭思暄
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Individual
Original Assignee
Individual
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Individual filed Critical Individual
Priority to CN201711089471.4A priority Critical patent/CN107648676A/zh
Publication of CN107648676A publication Critical patent/CN107648676A/zh
Pending legal-status Critical Current

Links

Classifications

    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61LMETHODS OR APPARATUS FOR STERILISING MATERIALS OR OBJECTS IN GENERAL; DISINFECTION, STERILISATION OR DEODORISATION OF AIR; CHEMICAL ASPECTS OF BANDAGES, DRESSINGS, ABSORBENT PADS OR SURGICAL ARTICLES; MATERIALS FOR BANDAGES, DRESSINGS, ABSORBENT PADS OR SURGICAL ARTICLES
    • A61L31/00Materials for other surgical articles, e.g. stents, stent-grafts, shunts, surgical drapes, guide wires, materials for adhesion prevention, occluding devices, surgical gloves, tissue fixation devices
    • A61L31/02Inorganic materials
    • A61L31/022Metals or alloys
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61LMETHODS OR APPARATUS FOR STERILISING MATERIALS OR OBJECTS IN GENERAL; DISINFECTION, STERILISATION OR DEODORISATION OF AIR; CHEMICAL ASPECTS OF BANDAGES, DRESSINGS, ABSORBENT PADS OR SURGICAL ARTICLES; MATERIALS FOR BANDAGES, DRESSINGS, ABSORBENT PADS OR SURGICAL ARTICLES
    • A61L31/00Materials for other surgical articles, e.g. stents, stent-grafts, shunts, surgical drapes, guide wires, materials for adhesion prevention, occluding devices, surgical gloves, tissue fixation devices
    • A61L31/14Materials characterised by their function or physical properties, e.g. injectable or lubricating compositions, shape-memory materials, surface modified materials
    • A61L31/148Materials at least partially resorbable by the body
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61LMETHODS OR APPARATUS FOR STERILISING MATERIALS OR OBJECTS IN GENERAL; DISINFECTION, STERILISATION OR DEODORISATION OF AIR; CHEMICAL ASPECTS OF BANDAGES, DRESSINGS, ABSORBENT PADS OR SURGICAL ARTICLES; MATERIALS FOR BANDAGES, DRESSINGS, ABSORBENT PADS OR SURGICAL ARTICLES
    • A61L31/00Materials for other surgical articles, e.g. stents, stent-grafts, shunts, surgical drapes, guide wires, materials for adhesion prevention, occluding devices, surgical gloves, tissue fixation devices
    • A61L31/14Materials characterised by their function or physical properties, e.g. injectable or lubricating compositions, shape-memory materials, surface modified materials
    • A61L31/16Biologically active materials, e.g. therapeutic substances
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61LMETHODS OR APPARATUS FOR STERILISING MATERIALS OR OBJECTS IN GENERAL; DISINFECTION, STERILISATION OR DEODORISATION OF AIR; CHEMICAL ASPECTS OF BANDAGES, DRESSINGS, ABSORBENT PADS OR SURGICAL ARTICLES; MATERIALS FOR BANDAGES, DRESSINGS, ABSORBENT PADS OR SURGICAL ARTICLES
    • A61L31/00Materials for other surgical articles, e.g. stents, stent-grafts, shunts, surgical drapes, guide wires, materials for adhesion prevention, occluding devices, surgical gloves, tissue fixation devices
    • A61L31/14Materials characterised by their function or physical properties, e.g. injectable or lubricating compositions, shape-memory materials, surface modified materials
    • A61L31/18Materials at least partially X-ray or laser opaque
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61LMETHODS OR APPARATUS FOR STERILISING MATERIALS OR OBJECTS IN GENERAL; DISINFECTION, STERILISATION OR DEODORISATION OF AIR; CHEMICAL ASPECTS OF BANDAGES, DRESSINGS, ABSORBENT PADS OR SURGICAL ARTICLES; MATERIALS FOR BANDAGES, DRESSINGS, ABSORBENT PADS OR SURGICAL ARTICLES
    • A61L2300/00Biologically active materials used in bandages, wound dressings, absorbent pads or medical devices
    • A61L2300/10Biologically active materials used in bandages, wound dressings, absorbent pads or medical devices containing or releasing inorganic materials
    • A61L2300/102Metals or metal compounds, e.g. salts such as bicarbonates, carbonates, oxides, zeolites, silicates
    • A61L2300/104Silver, e.g. silver sulfadiazine
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61LMETHODS OR APPARATUS FOR STERILISING MATERIALS OR OBJECTS IN GENERAL; DISINFECTION, STERILISATION OR DEODORISATION OF AIR; CHEMICAL ASPECTS OF BANDAGES, DRESSINGS, ABSORBENT PADS OR SURGICAL ARTICLES; MATERIALS FOR BANDAGES, DRESSINGS, ABSORBENT PADS OR SURGICAL ARTICLES
    • A61L2300/00Biologically active materials used in bandages, wound dressings, absorbent pads or medical devices
    • A61L2300/40Biologically active materials used in bandages, wound dressings, absorbent pads or medical devices characterised by a specific therapeutic activity or mode of action
    • A61L2300/404Biocides, antimicrobial agents, antiseptic agents
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61LMETHODS OR APPARATUS FOR STERILISING MATERIALS OR OBJECTS IN GENERAL; DISINFECTION, STERILISATION OR DEODORISATION OF AIR; CHEMICAL ASPECTS OF BANDAGES, DRESSINGS, ABSORBENT PADS OR SURGICAL ARTICLES; MATERIALS FOR BANDAGES, DRESSINGS, ABSORBENT PADS OR SURGICAL ARTICLES
    • A61L2300/00Biologically active materials used in bandages, wound dressings, absorbent pads or medical devices
    • A61L2300/40Biologically active materials used in bandages, wound dressings, absorbent pads or medical devices characterised by a specific therapeutic activity or mode of action
    • A61L2300/41Anti-inflammatory agents, e.g. NSAIDs

Abstract

本发明属于临床医学植入体技术领域,具体涉及一种可降解铁基心血管支架材料及其制备方法。本发明的技术方案如下:一种可降解铁基心血管支架材料,由铁粉、锰粉和银粉制备而成,铁粉、锰粉和银粉的质量比例为75:23:2,铁粉的纯度为99.99%,锰粉的纯度为99.99%,银粉的纯度为99.99%。本发明提供的支架材料具有优异力学性能、生物相容性、生物降解性及杀菌能力,完全满足临床医学介入疗法对植入体的要求。

Description

一种可降解铁基心血管支架材料及其制备方法
技术领域
本发明属于临床医学植入体技术领域,具体涉及一种可降解铁基心血管支架材料及其制备方法。
背景技术
随着社会的不断进步,心血管疾病的发病率逐渐增大,严重危害到人类的身体健康。目前心血管疾病通常采用介入疗法,由于血管支架的植入能够为心血管提供支撑,从而成为治疗心血管疾病最有效的方法之一。
临床上不仅希望可降解支架材料与生物体的良好适应性和生物相容性、无毒性,而且要求植入的支架能够在植入后最初的12个月内保持力学性能的完整性,并在之后的12-24个月内完全降解。传统的心血管支架材料一般采用可降解高分子、镁合金、铁基合金等。然而高分子材料不仅在降解过程中容易产生团聚现象,而且其X光显影效果差,不利于跟踪和定位,而镁合金的降解速率过快,不能保持所需的力学性能,因此均难以满足临床医学对可降解心血管支架材料的要求。铁基合金不仅具有优异的力学性能,而且是构成人体的必需微量元素之一,参与氧气的转运,铁离子还是很多酶促反应的辅助因子,直接影响DNA合成以及氧化还原酶的活性,因此铁基可降解材料作为可降解植入物时,其降解产生的铁离子可以被人体吸收参与新陈代谢,不会累积毒性,能够提供足够的安全保障,逐渐引起了临床医学的广泛关注。
发明内容
本发明提供一种可降解铁基心血管支架材料及其制备方法,该支架材料具有优异力学性能、生物相容性、生物降解性及杀菌能力,完全满足临床医学介入疗法对植入体的要求。
本发明的技术方案如下:
一种可降解铁基心血管支架材料,由铁粉、锰粉和银粉制备而成,铁粉、锰粉和银粉的质量比例为75:23:2,铁粉的纯度为99.99%,锰粉的纯度为99.99%,银粉的纯度为99.99%。
上述的可降解铁基心血管支架材料的制备方法,采用真空熔炼的方法,将所述铁粉、锰粉和银粉在15kg真空感应炉中于1600℃进行熔炼,在1100℃下保温2小时;将得到的合金锻造为20mm的圆棒,然后空冷,得到可降解铁基心血管支架材料。
本发明的有益效果为:通过在铁基合金中加入化学活性弱于铁的锰元素,能够加快铁在体液中的降解速率,同时锰可促进骨骼的生长发育,保护细胞中细粒体的完整,保持正常的脑功能,可改善肌体的造血功能,维持正常的糖代谢和脂肪代谢,可改善肌体的造血功能;而加入银元素使支架材料具有杀菌消炎的作用;所用铁粉、锰粉和银粉的质量比例为75:23:2,能够控制铁的降解速率,并符合人体心血管支架的降解速率要求;在1100℃下保温2小时,能使该合金形成纳米晶粒微观组织,增强其韧性;本发明所制备的可降解铁基心血管支架材料具有力学性能强、生物相容性好、生物降解能力合适、以及具有杀菌消炎的作用,符合医用植入材料的要求;在支架植入过程中以及后期的检查中,可以方便地通过X射线观察到心血管支架在体内的状况。
具体实施方式
一种可降解铁基心血管支架材料,由铁粉、锰粉和银粉制备而成,铁粉、锰粉和银粉的质量比例为75:23:2,铁粉的纯度为99.99%,锰粉的纯度为99.99%,银粉的纯度为99.99%。
上述的可降解铁基心血管支架材料的制备方法,采用真空熔炼的方法,将所述铁粉、锰粉和银粉在15kg真空感应炉中于1600℃进行熔炼,在1100℃下保温2小时;将得到的合金锻造为20mm的圆棒,然后空冷,得到可降解铁基心血管支架材料。
制得的可降解铁基心血管支架材料,其抗拉强度为1010MPa,断后延伸率为88%;在植入初期的12个月内具有完整的力学性能,在植入之后的16个月内完全降解,降解速度为1.02mm/年;其溶血率为2.45%,符合医用植入材料的要求。

Claims (2)

1.一种可降解铁基心血管支架材料,其特征在于,由铁粉、锰粉和银粉制备而成,铁粉、锰粉和银粉的质量比例为75:23:2,铁粉的纯度为99.99%,锰粉的纯度为99.99%,银粉的纯度为99.99%。
2.一种如权利要求1所述的可降解铁基心血管支架材料的制备方法,其特征在于,采用真空熔炼的方法,将所述铁粉、锰粉和银粉在15kg真空感应炉中于1600℃进行熔炼,在1100℃下保温2小时;将得到的合金锻造为20mm的圆棒,然后空冷,得到可降解铁基心血管支架材料。
CN201711089471.4A 2017-11-08 2017-11-08 一种可降解铁基心血管支架材料及其制备方法 Pending CN107648676A (zh)

Priority Applications (1)

Application Number Priority Date Filing Date Title
CN201711089471.4A CN107648676A (zh) 2017-11-08 2017-11-08 一种可降解铁基心血管支架材料及其制备方法

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
CN201711089471.4A CN107648676A (zh) 2017-11-08 2017-11-08 一种可降解铁基心血管支架材料及其制备方法

Publications (1)

Publication Number Publication Date
CN107648676A true CN107648676A (zh) 2018-02-02

Family

ID=61120820

Family Applications (1)

Application Number Title Priority Date Filing Date
CN201711089471.4A Pending CN107648676A (zh) 2017-11-08 2017-11-08 一种可降解铁基心血管支架材料及其制备方法

Country Status (1)

Country Link
CN (1) CN107648676A (zh)

Cited By (1)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
CN110607486A (zh) * 2019-10-22 2019-12-24 中南大学 一种兼具可降解和抗菌活性的铁基骨支架及其制备方法

Citations (6)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US20090306765A1 (en) * 2008-06-10 2009-12-10 Boston Scientific Scimed, Inc. Bioerodible Endoprosthesis
CN102776435A (zh) * 2011-05-13 2012-11-14 中国科学院金属研究所 一种可降解Fe-Mn-C三元铁合金材料及应用
CN102912171A (zh) * 2012-09-26 2013-02-06 中国科学院金属研究所 一种提高纯铁或铁合金生物降解速率的方法及其应用
CN104694848A (zh) * 2015-01-28 2015-06-10 燕山大学 一种生物可降解四元铁基合金材料及其制备方法
CN106191597A (zh) * 2016-09-13 2016-12-07 郑州大学 一种新型可生物降解Mg‑Zn‑Y‑Nd‑Ag抑菌镁合金及其制备方法
CN106729945A (zh) * 2017-01-19 2017-05-31 北京航空航天大学 可生物降解铁基合金止血夹及其制备方法

Patent Citations (6)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US20090306765A1 (en) * 2008-06-10 2009-12-10 Boston Scientific Scimed, Inc. Bioerodible Endoprosthesis
CN102776435A (zh) * 2011-05-13 2012-11-14 中国科学院金属研究所 一种可降解Fe-Mn-C三元铁合金材料及应用
CN102912171A (zh) * 2012-09-26 2013-02-06 中国科学院金属研究所 一种提高纯铁或铁合金生物降解速率的方法及其应用
CN104694848A (zh) * 2015-01-28 2015-06-10 燕山大学 一种生物可降解四元铁基合金材料及其制备方法
CN106191597A (zh) * 2016-09-13 2016-12-07 郑州大学 一种新型可生物降解Mg‑Zn‑Y‑Nd‑Ag抑菌镁合金及其制备方法
CN106729945A (zh) * 2017-01-19 2017-05-31 北京航空航天大学 可生物降解铁基合金止血夹及其制备方法

Non-Patent Citations (1)

* Cited by examiner, † Cited by third party
Title
徐文利等: "可降解铁基心血管支架材料的研究进展", 《材料导报A:综述篇》 *

Cited By (1)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
CN110607486A (zh) * 2019-10-22 2019-12-24 中南大学 一种兼具可降解和抗菌活性的铁基骨支架及其制备方法

Similar Documents

Publication Publication Date Title
CN106913916B (zh) 一种可降解的锌基合金植入材料在制备血管支架中的应用
Gu et al. A review on magnesium alloys as biodegradable materials
CN104212998B (zh) 一种Zn‑Mg系锌合金及其制备方法与应用
CN101015711B (zh) 一种可体液降解的医用植入体及其制备方法
CN103028149B (zh) 医用可降解Fe-Mg二元合金材料及其制备方法
CN101837145B (zh) 生物体内可降解高强韧耐蚀镁合金内植入材料
CN107496993B (zh) 一种医用可降解植入性金属材料
WO2017084363A1 (zh) 医用可降解Zn-Cu-X合金材料及其制备方法
CN104911427B (zh) 一种Mg‑Ca‑Sr‑Zn系镁合金及其制备方法与应用
CN106319287A (zh) 生物可降解医用Zn‑Li‑X系合金材料及制备与应用
CN103014465B (zh) 一种均匀降解的骨科植入镁合金材料
CN108315583B (zh) 一种Zn-Li-Mn系锌合金及其制备方法与应用
CN100368028C (zh) 生物体内可吸收的Mg-Zn两元镁合金材料
CN107190191B (zh) 一种生物医用镁合金及其制备方法
CN108277386A (zh) 一种Zn-Li-Mg系锌合金及其制备方法与应用
CN104195368A (zh) 一种Zn-Sr系锌合金及其制备方法与应用
CN103028148B (zh) 医用可降解Fe-Mg-X合金材料及其制备方法
CN101392344A (zh) 生物体内可降解Mg-Mn-Zn-Ca多元镁合金材料
CN104762542B (zh) 生物医用可降解吸收Mg‑Sr‑Cu合金材料及制备方法和应用
CN106086562A (zh) 生物体内可降解吻合钉及其生产工艺
CN100372574C (zh) 生物体内可吸收的Mg-Zn-Ca-Fe多元镁合金材料
CN107653410A (zh) 生物医用可降解吸收的镁合金及其制备方法和应用
CN106319309A (zh) 适用于医疗植入物的镁合金及其制造方法
CN108165782B (zh) 一种医用锌基合金带材及其制备方法
CN110694121A (zh) 一种体内可降解镁合金吻合钉及其制备方法

Legal Events

Date Code Title Description
PB01 Publication
PB01 Publication
SE01 Entry into force of request for substantive examination
SE01 Entry into force of request for substantive examination
RJ01 Rejection of invention patent application after publication
RJ01 Rejection of invention patent application after publication

Application publication date: 20180202